The current lack of standardization in MRI protocols leads to increased variability, particularly in semi-quantitative techniques such as MTR, and makes comparisons between studies almost impossible. A single subject with clinically stable RRMS travelled to seven North American sites and underwent two distinct 3T MRI sessions following a standardized MTR and qT1 protocol at each site. Both MTR and qT1 mapping have been shown to have potential in elucidating tissue characteristics and underlying pathology. This work demonstrated that use of carefully standardized protocols produces consistent quantitative and semi-quantitative measurements across sites in MS brain tissue in-vivo.
This abstract and the presentation materials are available to members only; a login is required.